APPENDICES - NIHR Health Technology Assessment Programme

More documents

Recommendations

Info

132 Appendix 5 18. Calzavara-Pinton PG, Venturini M, Sala R, Capezzera R, Parrinello G, Specchia C, et al. Methylaminolaevulinate-based photodynamic therapy of Bowen’s disease and squamous cell carcinoma. Br J Dermatol 2008;159:137–44. 19. Calzavara-Pinton PG, Zane C, Facchetti F, Carlino A, Blanzuoli L, Marocolo D, et al. [Photodynamic therapy of non-melanoma skin tumours with topical delta-aminolevulinic acid.] G Ital Dermatol Venereol 1997;132:15–21. 20. Carruth JAS, Barrett JM, Barnes DWH, Buchanan RB, Sansom JM. A trial of photodynamic therapy for the treatment of tumors of the skin and head and neck, and the results of an experimentalstudy to determine the Interrelationships between the tissue effects of ionizing-radiation and photodynamic therapy. SPIE Proceedings Series 1993;1616:14–19. 21. Cavicchini S, Moretti D, Tanzi C, Tourlaki A. MAL- PDT in “difficult to treat’’ Bowen’s disease. J Invest Dermatol 2006;126:S36. 22. Ceylan C, Erboz S, Ozdemir F, Alper S. Topical photodynamic therapy for intraepidermal epithelioma. J Eur Acad Dermatol Venereol 2002;16:292–4. 23. Ceylan C, Erboz S, Ozdemir F, Kazandi A. [The effectiveness of topical photodynamic therapy in actinic.] Deri Hast Frengi Ars 2001;35:213–18. 24. Cochito M, Campos Lopes JM, Leite L. Topical photodynamic therapy in a case of Bowen’s disease of the face. Skin Cancer 1996;11:215–18. 25. Counters J, Zelickson B, Coles C, Selim M. A comparison of the V-beam and IPL in photodynamic therapy for reduction of actinic keratosis. Lasers Surg Med 2004;34:42. 26. de Haas ER, Sterenborg HJ, Neumann HA, Robinson DJ. The influence of light fractionation on the response of superficial skin cancer to aminolevulinic-acid photodynamic therapy. J Invest Dermatol 2006;126:S73. 27. de Haas ERM, de Vijlder HC, Sterenborg HJCM, Neumann HAM, Robinson DJ. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for nonmelanoma skin cancer. J Eur Acad Dermatol Venereol 2008;22:426–30. 28. Dijkstra AT, Majoie IM, van Dongen JW, van Weelden H, van Vloten WA. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen’s disease and basal cell carcinoma. J Eur Acad Dermatol Venereol 2001;15:550–4. 29. Dragieva G, Hafner J, Dummer R, Schmid- Grendelmeier P, Roos M, Prinz BM, et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipients. Transplantation 2004;77:115–21. 30. Erboz S, Ceylan C, Ozdemir F, Kazandi A, Ozol A. [Photodynamic treatment in solar keratosis.] Deri Hast Frengi Ars 1999;33:75–8. 31. Fernandez-Guarino M, Harto A, Perez-Garcia B, Martin-Gonzalez M, Urrutia S, Jaen P. Photodynamic therapy in disseminated superficial actinic porokeratosis. J Eur Acad Dermatol Venereol 2009;23:176–7. 32. Fijan S, Honigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using deltaaminolaevulinic acid and desferrioxamine. Br J Dermatol 1995;133:282–8. 33. Fink-Puches R, Hofer A, Smolle J, Kerl H, Wolf P. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. J Photochem Photobiol B 1997;41:145–51. 34. Fowler JF, Jr, Zax RH. Aminolevulinic acid hydrochloride with photodynamic therapy: efficacy outcomes and recurrence 4 years after treatment. Cutis 2002;69:2–7. 35. Fritsch C, Stege H, Saalmann G, Goerz G, Ruzicka T, Krutmann J. Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photodermatol Photoimmunol Photomed 1997;13:181–5. 36. Gniazdowska B, Rueff F, Hillemanns P, Przybilla B. Allergic contact dermatitis from deltaaminolevulinic acid used for photodynamic therapy. Contact Dermatitis 1998;38:348–9. 37. Gold MH. Treatment of actinic cheilitis using photodynamic therapy with methylaminolevulinate: report of three cases [Commentary]. Dermatol Surg 2005;31:1348. 38. Goldman M, Atkin D. ALA/PDT in the treatment of actinic keratosis: spot versus confluent therapy. J Cosmetic Laser Ther 2003;5:107–10. 39. Gonzalez-Perez R, Garcia JG, Badiola IB, Calleja JMV, Sanchez SA, Diaz-Perez JL. [Topical photodynamic therapy with 5-amino levulinic acid: Experience at the Hospital of Cruces.] Actas Dermosifiliogr 1997;88:561–5.
DOI: 10.3310/hta14370 Health Technology Assessment 2010; Vol. 14: No. 37 40. Guarneri C, Vaccaro M. Erosive pustular dermatosis of the scalp following topical methylaminolaevulinate photodynamic therapy. J Am Acad Dermatol 2009;60:521–2. 41. Gupta G, Morton CA, Whitehurst C, Moore JV, MacKie RM. Photodynamic therapy with mesotetra(hydroxyphenyl) chlorin in the topical treatment of Bowen’s disease and basal cell carcinoma. Br J Dermatol 1999;141:385–6. 42. Ha XW, Sun XM, Xie JG, Fan XJ, Zhang YH, Mei QC, et al. Clinical use of hematoporphyrin derivative in malignant tumors. Chin Med J 1983;96:754–8. 43. Hauschild A, Lischner S, Lange-Asschenfeldt B, Egberts F. Treatment of actinic cheilitis using photodynamic therapy with methyl aminolevulinate: report of three cases. Dermatol Surg 2005;31:1344–7. 44. Hegyi J, Frey T, Arenberger P. The treatment of unilesional mycosis fungoides with methyl aminolevulinate-photodynamic therapy. J Eur Acad Dermatol Venereol 2008;22:1134–5. 45. Hyung SK, Jong YY, Kwang HC, Oh SK, Sang EM, Vinciullo C. Topical photodynamic therapy using intense pulsed light for treatment of actinic keratosis: clinical and histopathologic evaluation [Commentary]. Dermatol Surg 2005;31:33–7. 46. Itoh Y, Ninomiya Y, Henta T, Tajima S, Ishibashi A. Topical delta-aminolevulinic acid-based photodynamic therapy for Japanese actinic keratoses. J Dermatol 2000;27:513–18. 47. Jeffes EW, McCullough JL, Weinstein GD, Fergin PE, Nelson JS, Shull TF, et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. Arch Dermatol 1997;133:727–32. 48. Jiraskova M, Jirasek L, Stork J, Vosmik F, Jirsa M. [Photodynamic diagnosis and therapy in dermatology. Experience with use of TPPS4 in skin diseases.] Cas Lek Cesk 2003;142:493–9. 49. Jiraskova M, Vosmik F, Krajsova I, Lapes M, Jirsa M. [Experience with photodynamic therapy in some skin affections.] Cesk Dermatol 1999;74:161–7. 50. Jiraskova M, Vosmik F, Lapes M, Jirsa M, Stadnik B. Experiences with local photodynamic therapy with TPPS4 and non-coherent light. Biomed Tech 1997;42(Suppl.):447–8. 51. Jones CM, Mang T, Cooper M, Wilson BD, Stoll HL, Jr. Photodynamic therapy in the treatment of Bowen’s disease. J Am Acad Dermatol 1992;27:979–82. © 2010 Queen’s Printer and Controller of HMSO. All rights reserved. 52. Jungersted JM, Dam TN, Bryld LE, Agner T. Allergic reactions to Metvix (ALA-ME). Contact Dermatitis 2008;58:184–6. 53. Kaae J, Philipsen PA, Haedersdal M, Wulf HC. Immediate whealing urticaria in red light exposed areas during photodynamic therapy. Acta Dermatol Venereol 2008;88:480–3. 54. Kacerovska D, Pizinger K, Majer F, Smid F. Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract: a pilot study. Photochem Photobiol 2008;84:779–85. 55. Kacerovska D, Pizinger K, Resl V, Cetkovska P, Jirsa M, Smid F. [Comparison of efficacy between the two photosensitizers in the photodynamic therapy of cutaneous tumours.] Cesko Dermatol 2006;81:148–52. 56. Karrer S, Baumler W, Abels C, Hohenleutner U, Landthaler M, Szeimies RM. Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Lasers Surg Med 1999;25:51–9. 57. Karrer S, Szeimies RM, Landthaler M. Topical photodynamic therapy with 5-ala in the treatment of arsenic-induced skin tumors. SPIE Proceedings Series 1995;2371:222–5. 58. Karrer S, Szeimies RM, Sauerwald A, Landthaler M. Topical photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic keratoses: a first clinical study. SPIE Proceedings Series 1996;2625:48–50. 59. Kasche A, Luderschmidt S, Ring J, Hein R. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol 2006;5:353–6. 60. Kawczyk-Krupka A, Sieron A, Suwata-Jurczyk B, Adamek M. [Photodynamic therapy (PDT) using topically applied delta-aminolevulinic acid (ALA) for the treatment of malignant skin tumours.] Przegl Dermatol 2000;87:235–40. 61. Kerr AC, Ferguson J, Ibbotson SH. Acute phototoxicity with urticarial features during topical 5-aminolaevulinic acid photodynamic therapy. Clin Exp Dermatol 2007;32:201–2. 62. Kim EH, Kang HY, Lee E-S, Kim YC. Mycosis fungoides showing inCR to topical 5-aminolaevulinic acid phototherapy. Eur J Dermatol 2007;17:343–5. 63. Kim HS, Song KH, Kim KH. [Photodynamic therapy of actinic keratoses using 585nm dye laser and variable lights.] Korean J Dermatol 2005;43:53–9. 133
Page 1 and 2: Appendices July 2010 10.3310/hta143
Page 3: DOI: 10.3310/hta14370 Health Techno
Page 7 and 8: DOI: 10.3310/hta14370 Health Techno
Page 12 and 13: 140 Appendix 6 18. Biel MA. Photody
Page 14 and 15: 142 Appendix 6 63. Gonzalez-Perez R
Page 16 and 17: 144 Appendix 6 treated with photody
Page 18 and 19: 146 Appendix 6 aminolevulinic acid
Page 20 and 21: 148 Appendix 6 carcinomas: 5 years
Page 38 and 39: 166 Appendix 9 photodynamic therapy
Page 40 and 41: 168 Appendix 9 of early-stage lung
Page 42 and 43: 170 Appendix 9 107. Okunaka T, Kato
Page 44 and 45: 172 Appendix 9 152. Kato H, Konaka
Page 54 and 55:
182 Appendix 12 as salvage treatmen
Page 56 and 57:
184 Appendix 12 63. Lorenz KJ, Maie
Page 58 and 59:
186 Appendix 12 107. Biel MA. Photo
Page 60 and 61:
188 Appendix 13 Study details Popul
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Appendix 13 214 Study details Popul
Page 89 and 90:
DOI: 10.3310/hta14370 Health Techno
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Study details Population details Tr
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153:
Page 156 and 157:
Page 158 and 159:
Appendix 21 286 Study details Popul
Page 162:
Feedback The HTA programme and the
show all

APPENDICES - NIHR Health Technology Assessment Programme

Create successful ePaper yourself

Delete template?

Save as template?